The potential of a liquid biopsy extends to ROS1-rearranged NSCLC; however, the data from previous studies on ROS1-rearranged NSCLC are limited compared to other molecular subsets of NSCLC [34,35]. This evidence concerns the gene ROS1 and non-small cell lung carcinoma.